Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisapride for Feeding Intolerance in Premature Infants
NCT01281566Phase 4Terminated
- Sponsor
- Johnson & Johnson
- Start
- Mar 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cisapride in feeding intolerance, sponsored by Johnson & Johnson. Started Mar 2003; status: terminated.
02
Drugs
cisapride
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT01281566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281566.